111 to Announce Second Quarter 2020 Unaudited Financial Results on August 20, 2020

SHANGHAI, July 31, 2020 — 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a Company dedicated to digitally connecting patients with drugs and healthcare services in China, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2020, before the U.S. market opens…

Carromex Unveils Pharma Leads, a Groundbreaking Cloud-based Platform for Rapid Drug Analysis and Discovery

Mathematical Breakthrough by Australia-based Research Team Leads to a Shortening of Drug Discovery Times and Efficacy Analysis SYDNEY and MELBOURNE, Australia, July 10, 2020 — Carromex, a mathematical research-based innovation company based in Australia, unveiled a new cloud-based pharmaceutical software platform called Pharma Leads https://carromex.com/products/pharma-leads/, that is set to significantly contribute to…

Clarivate Introduces Next Generation Insights Platform with Cortellis Generics Intelligence

Enhanced Newport platform allows for comprehensive and accurate analysis of market, API and patent data from a single application LONDON, July 1, 2020 — Clarivate Plc (NYSE:CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the launch of Cortellis Generics Intelligence™ to…

Berkeley Lights Launches Two New Capabilities in the Opto Cell Therapy Development 1.0 Workflow to Accelerate the Creation Of Effective Cancer Immunotherapies

The new multiplex cytokine and cytotoxicity assays as a part of the Opto Cell Therapy Development 1.0 workflow will help users of the Berkeley Lights’ platform develop cancer immunotherapies faster EMERYVILLE, Calif., April 28, 2020 /PRNewswire/ — Today, Berkeley Lights, Inc.,…